Patients classified as IPI group 3 (high-intermediate) or NKPI group 4 showed a trend toward worse 5-year OS rates than those of other groups, although the differences were not statistically significant ( p =0.052 and 0.434, respectively).
← all excerpts
The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma.
1
—
—